Vicarious Surgical (RBOT) to Release Earnings on Tuesday

Key Points

• Vicarious Surgical (NYSE:RBOT) is set to announce its Q2 2025 earnings on August 12th, with analysts predicting an earnings loss of **($2.61)** per share.
• The company's previous earnings report showed a loss of **($2.58)** per share, which exceeded the consensus estimate by **$0.03**.
• Vicarious Surgical operates a unique **single-incision surgical robot** aimed at minimizing invasive surgical procedures, contributing to the innovative landscape of medical robotics.

Vicarious Surgical (NYSE:RBOT - Get Free Report) is anticipated to announce its Q2 2025 earnings results after the market closes on Tuesday, August 12th. Analysts expect the company to announce earnings of ($2.61) per share for the quarter.

Vicarious Surgical (NYSE:RBOT - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported ($2.58) EPS for the quarter, topping the consensus estimate of ($2.61) by $0.03. On average, analysts expect Vicarious Surgical to post $-11 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

Vicarious Surgical Stock Down 4.4%

Shares of NYSE RBOT opened at $8.84 on Thursday. Vicarious Surgical has a 12-month low of $4.27 and a 12-month high of $19.00. The firm has a market cap of $52.42 million, a PE ratio of -0.85 and a beta of 1.41. The company's fifty day simple moving average is $8.61 and its 200 day simple moving average is $9.06.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.